Geron股票因FDA批准治療血液癌症藥物而飆升

Reported 6 months ago

Geron（GERN）的股票周五交易高漲，主要是因為最近獲得美國食品和藥物管理局（FDA）批准的該公司血液疾病藥物Rytelo。該治療適用於成人低至中等風險的骨髓異形增生綜合症，一種癌症类型。

You may also interested in these wikis

Significant Developments in Cryptocurrency This Week

ByteDance Sues Former Intern for $1.1 Million Over AI Breach

MUFG Plans Potential Acquisition of WealthNavi

Trudeau Warns That Trump's Tariff Threats Could Raise Prices for Americans

Retailers Rely on Black Friday to Boost Holiday Sales

LIV Golf Considers Partnership with DP World Tour

Bitcoin Surges as Pro-Crypto Candidates Likely to Lead US Regulatory Bodies

Is Rigetti Computing the Next Nvidia in Quantum Computing?

Saudi Fund's Budget Cuts Signal Shift in Project Priorities

Nvidia's Stock Potential Over the Next Two Years

Back to all Wikis